Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Donatello Gasparro"'
Autor:
Donatello Gasparro, Maura Scarlattei, Enrico Maria Silini, Silvia Migliari, Giorgio Baldari, Veronica Cervati, Tiziano Graziani, Nicoletta Campanini, Umberto Maestroni, Livia Ruffini
Publikováno v:
Diagnostics, Vol 13, Iss 19, p 3082 (2023)
In oligo-metastatic renal cell carcinoma (RCC), neither computed tomography (CT) nor bone scan is sensitive enough to detect small tumor deposits hampering early treatment and potential cure. Prostate-specific membrane antigen (PSMA) is a transmembra
Externí odkaz:
https://doaj.org/article/99ef8173030e4625a19ee8e4e94461ba
Autor:
Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background This multi-institutional retrospective real life study was conducted in 22 Italian Oncology Centers and evaluated the role of Axitinib in second line treatment in not selected mRCC patients. Methods 148 mRCC patients were evaluate
Externí odkaz:
https://doaj.org/article/ce45764abe174be68515afe7c66b3135
Autor:
Daniele Santini, Saverio Cinieri, Donatello Gasparro, Roberto Bordonaro, Pamela Francesca Guglielmini, Vincenzo Emanuele Chiuri, Rolando M D'Angelillo, Giovanni Luca Ceresoli, Daniele Fagnani, Mirko Acquati, Manlio Mencoboni, Gaetano Lanzetta, Donata Sartori, Paolo Carlini, Fabiana Panebianco, Patrizia Beccaglia, Giuseppe Procopio
Publikováno v:
Journal of Bone Oncology, Vol 26, Iss , Pp 100341- (2021)
Background: Bone remodeling is disrupted in metastatic disease, which affects > 70% of metastatic castration-resistant prostate cancer (mCRPC) patients. As a result, abnormal levels of specific bone turnover biomarkers (BTMs) are released. In this pr
Externí odkaz:
https://doaj.org/article/81c32569eace4c8faac43a497b6f1d4c
Autor:
Giuseppe Procopio, Vincenzo Emanuele Chiuri, Monica Giordano, Giovanna Mantini, Roberto Maisano, Roberto Bordonaro, Nicola Calvani, Gaetano Facchini, Sabino De Placido, Mario Airoldi, Andrea Sbrana, Donatello Gasparro, Giuseppe Mario Ludovico, Pamela Guglielmini, Emanuele Naglieri, Daniele Fagnani, Massimo Aglietta, Luigi Schips, Patrizia Beccaglia, Alessandro Sciarra, Lorenzo Livi, Daniele Santini
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Real-world data on chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone plus prednisone are limited, largely deriving from small retrospective studies. Methods: ABitude is an I
Externí odkaz:
https://doaj.org/article/4158cb19afc64d579cb889f839a83fac
Autor:
Michela Verzè, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, Donatello Gasparro, Rita Nizzoli, Cinzia Azzoni, Lorena Bottarelli, Anna Squadrilli, Paola Mozzoni, Marcello Tiseo
Publikováno v:
Cancers, Vol 13, Iss 21, p 5403 (2021)
In order to study alternatives at the tissue biopsy to study EGFR status in NSCLC patients, we evaluated three different liquid biopsy platforms (plasma, urine and exhaled breath condensate, EBC). We also reviewed the literature of the cfDNA biologic
Externí odkaz:
https://doaj.org/article/baf6dfbf7bf446ec935f7672e54ef210
Autor:
Roberta Manuguerra, Antonino Sammartano, Priscilla Guglielmo, Maura Scarlattei, Umberto Maestroni, Livia Ruffini, Giorgio Baldari, Silvia Migliari, Donatello Gasparro
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 41:322-324
Publikováno v:
World Journal of Oncology
Metastatic renal cell carcinoma (mRCC) may present with a wide range of clinical pictures. Reportedly, paraneoplastic syndromes are the first sign in 20% of cases and only 15% of cases show the classic triad (flank pain, gross hematuria, and palpable
Autor:
Ugo De Giorgi, Giovanni Bozza, Roberto Sabbatini, Maurizio Nicodemo, Massimo Aglietta, Sabrina Rossetti, Franco Morelli, Giovanni L. Pappagallo, Giovanni Re, Camillo Porta, Giorgia Razzini, Lucia Fratino, Gaetano Facchini, Michele Aieta, Alessandro D'Angelo, Francesco Carrozza, Marco Maruzzo, Orazio Caffo, Paola Ermacora, Isabella Vittimberga, Erica Palesandro, Stefania Kinspergher, Sebastiano Buti, Monica Giordano, Daniela Scapoli, Franco Nolè, Luca Galli, Claudia Mucciarini, Donatello Gasparro, Cinzia Ortega, Chiara Ciccarese, Elena Verri, Francesca Maines, Giuseppe Schepisi, Francesca Valcamonico, Roberto Iacovelli, Antonello Veccia, Vittorina Zagonel, Caterina Messina, Donata Sartori, Paolo Lippe
Publikováno v:
European Journal of Cancer. 155:56-63
Background Pre-clinical data suggest that docetaxel and enzalutamide interfere with androgen receptor translocation and signalling. The aim of this study is to assess the efficacy of their concurrent administration in the first-line treatment for met
Autor:
Arlene O Siefker-Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert A Huddart, Earle F Burgess, Mark T Fleming, Arash Rezazadeh Kalebasty, Begoña Mellado, Sergei Varlamov, Monika Joshi, Ignacio Duran, Scott T Tagawa, Yousef Zakharia, Sydney Akapame, Ademi E Santiago-Walker, Manish Monga, Anne O'Hagan, Yohann Loriot, Scott Tagawa, Aude Flechon, Boris Alexeev, Sergey Varlamov, Robert Huddart, Earle Burgess, Arash Rezazadeh, Arlene Siefker-Radtke, Yann Vano, Donatello Gasparro, Alketa Hamzaj, Eugeniy Kopyltsov, Jesus Gracia Donas, Begona Mellado, Omi Parikh, Peter Schatteman, Stephane Culine, Nadine Houédé, Sylvie Zanetta, Gaetano Facchini, Giorgio Scagliotti, Giovanni Schinzari, Jae Lyun Lee, Mikhail Shkolnik, Mark Fleming, Monica Joshi, Peter O'Donnell, Herbert Stöger, Karel Decaestecker, Luc Dirix, Jean Pascal Machiels, Dephine Borchiellini, Remy Delva, Frederic Rolland, Boris Hadaschik, Margitta Retz, Eli Rosenbaum, Umberto Basso, Alessandra Mosca, Hyo Jin Lee, Dong Bok Shin, Cristina Cebotaru, Victor Moreno, Jose Luis Perez Gracia, Alvaro Pinto, Wen-Pin Su, Shian-Shiang Wang, John Hainsworth, Ian Schnadig, Sandhya Srinivas, Nicholas Vogelzang, Wolfgang Loidl, Johannes Meran, Marine Gross Goupil, Florence Joly, Florian Imkamp, Theodor Klotz, Susanne Krege, Matthias May, Wolfgang Schultze-Seemann, Arne Strauss, Uwe Zimmermann, Daniel Keizman, Avivit Peer, Avishai Sella, Rossana Berardi, Ugo De Giorgi, Cora Nanette Sternberg, Sun Young Rha, Iurie Bulat, Adel Izmailov, Vsevolod Matveev, Vladimir Vladimirov, Joan Carles, Albert Font, Maribel Saez, Isabel Syndikus, Kathryn Tarver, Leonard Appleman, John Burke, Nancy Dawson, Sharad Jain
Publikováno v:
The Lancet Oncology, Vol. 23, no.2, p. 248-258 (2022)
Background Erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, was shown to be clinically active and tolerable in patients with advanced urothelial carcinoma and prespecified FGFR alterations in the primary analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f518baf9decca47c67f21a5a6035817d
https://hdl.handle.net/2078.1/275404
https://hdl.handle.net/2078.1/275404
Autor:
Stefano Bola, Maura Scarlattei, Priscilla Guglielmo, Antonino Sammartano, Umberto Maestroni, Silvia Migliari, Livia Ruffini, Donatello Gasparro, Giorgio Baldari
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:3337-3339